Response to Direct Acting Antivirals for hepatitis C treatment in vertically HIV/HCV co-infected patients.

Direct-acting Antivirals (DAAs) for HCV treatment have improved tolerance and efficacy among adults, but experience in vertical transmission is scarce. In our vertically HIV/HCV co-infected youths Cohort of 58 patients, DAA achieved excellent rates of cure among naive and pre-treated individuals. Treating vertically-infected seems important as 29.6% displayed advanced fibrosis at treatment initiation.